Phoenix, United States
Ashion Analytics, operating under the slogan "We are an Exact Sciences sequencing-based Clinical laboratory. We tap into the power of the human genome," is a key player in the Biotechnology and Health Care sectors. Founded in 2014, the company is headquartered in the United States.
As a part of Genomic Health, Inc., an Exact Sciences Laboratory, Ashion is both CAP-accredited and CLIA-certified. The company is dedicated to mainstreaming precision medicine in oncology. This is achieved through extensive scientific and clinical expertise aimed at offering personalized cancer treatment options. Their latest innovation, the GEM ExTra® assay, stands out by addressing all DNA-coding regions and providing a comprehensive genomic analysis through both exome and transcriptome evaluations.
While Ashion Analytics has yet to receive its last investment, its integration with Genomic Health, Inc. positions it well for future growth and partnerships in precision medicine. This makes Ashion a promising candidate for investors focused on transformative healthcare technologies.
